Foghorn Therapeutics Inc. (FHTX)

Foghorn Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	301	272	267	848	726	-
Market Cap Growth	10.20%	2.10%	-68.56%	16.85%	-	-
Enterprise Value	136	82	-29	751	620	-1
PE Ratio	-	-2.77	-2.45	-8.37	-10.55	-
PS Ratio	8.88	7.97	13.87	643.13	1688.24	-
PB Ratio	-2.93	-3.53	2381.22	8.76	4.97	-
P/FCF Ratio	-2.44	-2.28	1.39	-15.84	-15.37	-
P/OCF Ratio	-2.46	-2.31	1.38	-16.88	-23.20	-
EV/Sales Ratio	4.00	2.39	-1.52	569.06	1442.87	-
EV/EBITDA Ratio	-1.49	-0.95	0.29	-8.17	-9.96	0.01
EV/EBIT Ratio	-1.35	-0.87	0.27	-7.55	-9.15	0.01
EV/FCF Ratio	-1.03	-0.68	-0.15	-14.01	-13.14	0.01
Debt / Equity Ratio	-0.44	-0.58	459.88	0.60	0.56	-0.19
Debt / EBITDA Ratio	-0.53	-0.53	-0.51	-0.63	-1.32	-0.34
Debt / FCF Ratio	-0.37	-0.38	0.27	-1.09	-1.74	-0.35
Quick Ratio	4.00	4.03	6.29	9.37	9.95	1.36
Current Ratio	4.06	4.11	6.37	9.44	10.12	1.34
Asset Turnover	0.11	0.10	0.04	0.01	0.00	0
Interest Coverage	-	-	-	-52.16	-69.28	-93.68
Return on Equity (ROE)	132.10%	188.80%	-301.50%	-99.50%	-236.50%	80.30%
Return on Assets (ROA)	-31.10%	-30.00%	-24.40%	-35.40%	-49.50%	-156.40%
Return on Capital (ROIC)	188.57%	335.98%	-226.93%	-64.90%	-30.03%	71.56%
Earnings Yield	-30.88%	-36.15%	-40.83%	-11.94%	-9.48%	-
FCF Yield	-38.86%	-43.82%	72.14%	-6.31%	-6.50%	-
Buyback Yield / Dilution	-1.48%	-0.92%	-11.89%	-236.49%	-163.53%	-42.23%
Total Shareholder Return	-1.48%	-0.92%	-11.89%	-236.49%	-163.53%	-42.23%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).